Probabilistic (Bayesian) Modeling of Gene Expression in Transplant Glomerulopathy

Eric A. Elster(National Institutes of Health), Roslyn B. Mannon(University of Nebraska Medical Center), David B. Leeser(Naval Medical Research Command), Orlena Cheng(National Institutes of Health), Trevor S. Brown(Pennsylvania State University), Jason Hawksworth(Naval Medical Research Command), Michael Ring(National Institutes of Health), Douglas K. Tadaki(Walter Reed National Military Medical Center), John Eberhardt, David E. Kleiner(National Institutes of Health)
Journal of Molecular Diagnostics
August 5, 2010
10.2353/jmoldx.2010.090101
Cited by 13

Related Papers

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k